Skip Navigation

This Article
Right arrow FREE Full Text (Print PDF) Freely available
Right arrow FREE Full Text (Screen PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Peters, B.
Right arrow Articles by Weng, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, B.
Right arrow Articles by Weng, Z.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Bioinformatics Vol. 19 no. 14 2003
Pages 1765-1772
© 2003 Oxford University Press

Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules

Björn Peters 1, Weiwei Tong 2, John Sidney 3, Alessandro Sette 3 and Zhiping Weng 2,4,*

1 Institut für Biochemie, Charite, Humboldt Universität Berlin, Monbijoustr. 2, 10117 Berlin, Germany, 2 Department of Biomedical Engineering, 44 Cummington Street, Boston University, Boston, MA 02215, USA, 3 La Jolla Institute for Allergy and Immunology, 10355 Science Center Drive, La Jolla, CA 92121, USA and 4 Bioinformatics Program, 48 Cummington Street, Boston University, Boston, MA 02215, USA

Received on October 22, 2002 ; revised on February 13, 2003 ; accepted on April 25, 2003

Motivation: Various methods have been proposed to predict the binding affinities of peptides to Major Histocompatibility Complex class I (MHC-I) molecules based on experimental binding data. They can be classified into two groups: (1) AIB methods that assume independent contributions of all peptide positions to the binding to MHC-I molecule (e.g. scoring matrices) and (2) general methods which can take into account interactions between different positions (e.g. artificial neural networks). We aim to compare the prediction accuracies of these methods, and quantify the impact of interactions between peptide positions.

Results: We compared several previously published and widely used methods and discovered that the best AIB methods gave significantly better predictions than three previously published general methods, possibly due to the lack of a sufficient training data for the general methods. The best results, however, were achieved with our newly developed general method, which combined a matrix describing independent binding with pair coefficients describing pair-wise interactions between peptide positions. The pair coefficients consistently but only slightly improved prediction accuracy, and were much smaller than the matrix entries. This explains why neglecting them—as is done in AIB methods—can still lead to good predictions.

Availability: The new prediction model is implemented at http://zlab.bu.edu/SMM. The underlying matrix and pair coefficients are also available as supplementary materials.

Contact: zhiping{at}bu.edu

* To whom correspondence should be addressed.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Rao, A. I. C. A. Fontaine Costa, D. van Baarle, and C. Kesmir
A Comparative Study of HLA Binding Affinity and Ligand Diversity: Implications for Generating Immunodominant CD8+ T Cell Responses
J. Immunol., February 1, 2009; 182(3): 1526 - 1532.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Kondo, B. Maecker, M. R. Weihrauch, C. Wickenhauser, W. Zeng, L. M. Nadler, J. L. Schultze, and M. S. von Bergwelt-Baildon
Cyclin D1-Specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy
Clin. Cancer Res., October 15, 2008; 14(20): 6574 - 6579.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Q. Zhang, P. Wang, Y. Kim, P. Haste-Andersen, J. Beaver, P. E. Bourne, H.-H. Bui, S. Buus, S. Frankild, J. Greenbaum, et al.
Immune epitope database analysis resource (IEDB-AR)
Nucleic Acids Res., July 1, 2008; 36(suppl_2): W513 - W518.
[Abstract] [Full Text] [PDF]


Home page
Brief BioinformHome page
J. C. Tong, T. W. Tan, and S. Ranganathan
Methods and protocols for prediction of immunogenic epitopes
Brief Bioinform, March 1, 2007; 8(2): 96 - 108.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
S. Zhu, K. Udaka, J. Sidney, A. Sette, K. F. Aoki-Kinoshita, and H. Mamitsuka
Improving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules
Bioinformatics, July 1, 2006; 22(13): 1648 - 1655.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. A. Reche and E. L. Reinherz
PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands
Nucleic Acids Res., July 1, 2005; 33(suppl_2): W138 - W142.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. L. Zhang, A. M. Khan, K. N. Srinivasan, J. T. August, and V. Brusic
MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides
Nucleic Acids Res., July 1, 2005; 33(suppl_2): W172 - W179.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Sidney, S. Southwood, V. Pasquetto, and A. Sette
Simultaneous Prediction of Binding Capacity for Multiple Molecules of the HLA B44 Supertype
J. Immunol., December 1, 2003; 171(11): 5964 - 5974.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.